Clinical Trials

57 enrolled

Locally Advanced Head and Neck Carcinoma

NCT05538533 2026-03-10

Hypofractionated Preoperative Radiation for Head and Neck Cancers (HyPR-HN)

12 enrolled

Head and Neck Neoplasms

NCT00498875 2026-03-09

Depression and Adherence in Head and Neck Cancer

185 enrolled

Depression, Head and Neck Neoplasms, Oropharyngeal Neoplasms

NCT04030455 2026-03-09

Cisplatin, Docetaxel, and Pembrolizumab in Treating Patients With Stage II-III Laryngeal Cancer

28 enrolled 13 charts

Phase 3 Active not recruiting

Squamous Cell Carcinoma of Head and Neck, Laryngeal Neoplasms

NCT03570021 2026-03-06

ESTIMABL3

352 enrolled

Thyroid Neoplasms

NCT06674499 2026-03-06

Development and Evaluation of a Self-Management Model for Cancer Rehabilitation

144 enrolled

Head and Neck Neoplasms

NCT00542373 2026-03-05

Widefield Fluorescence and Reflectance Imaging Systems and Oral Tissue Samples in Monitoring Participants at Risk for Developing Oral Cancer

Classical hematologyDermatologicHead & Neck

338 enrolled

Erythroplasia, Fanconi Anemia, Lichen Planus, Mouth Neoplasms, Tobacco Use Disorder, Leukokeratosis, Hereditary Mucosal

NCT03888651 2026-03-05

Clinical Data Collection in Studying Clinical Factors Associated With Post-Surgery Chronic Opioid Use in Patients With Head and Neck Cancers

125 enrolled

Head and Neck Carcinoma

NCT02597426 2026-03-04

Nasopharyngeal Carcinoma Post IMRT

108 enrolled

Nasopharyngeal Carcinoma

NCT04502407 2026-03-04

Trial of De-Intensified Post-operative Chemoradiation Following Robotic Surgery for HPV-positive Oropharyngeal Cancer

40 enrolled

HPV Positive Oropharyngeal Squamous Cell Carcinoma

NCT05570851 2026-03-04

Alcohol Cessation Among Head and Neck Cancer Survivors

138 enrolled

Phase 1/2 Active not recruiting

Alcohol Drinking, Depression, Head and Neck Neoplasms, Social Isolation, Substance-Related Disorders

NCT03781986 2026-03-03

APG-115 in Salivary Gland Cancer Trial

41 enrolled

Carcinoma, Adenoid Cystic, Salivary Gland Neoplasms

NCT04321954 2026-02-27

Lenvatinib in Locally Advanced Invasive Thyroid Cancer

Phase EARLY_PHASE1 Active not recruiting

Differentiated Thyroid Cancer

NCT07435415 2026-02-27

Local Injection Methylene Blue Combined With Radiation in HNSCC Patients

10 enrolled

Head and Neck Neoplasms

NCT03416686 2026-02-25

METATHYRAF

14 enrolled

Differentiated Thyroid Cancer

NCT03565783 2026-02-25

Cemiplimab in Treating Patients With Recurrent and Resectable Stage II-IV Head and Neck Cutaneous Squamous Cell Cancer Before Surgery

Phase 2/3 Active not recruiting

44 enrolled

DermatologicHead & Neck

Recurrent Cutaneous Squamous Cell Carcinoma of the Head and Neck

NCT07434206 2026-02-25

Safety and Efficacy of Dexmedetomidine in Controlling Hemodynamics During Resection of Active Thyroid Secreting Tumors

80 enrolled

Phase 3 Active not recruiting

Thyroid Neoplasms

NCT01893307 2026-02-24

Intensity-Modulated Proton Beam Therapy or Intensity-Modulated Photon Therapy in Treating Patients With Stage III-IVB Oropharyngeal Cancer

440 enrolled

Squamous Cell Carcinoma of Head and Neck

NCT04305366 2026-02-24

MicroRNA Markers in Head and Neck Cancers

225 enrolled

Squamous Cell Carcinoma of Head and Neck

NCT03174275 2026-02-23

Carboplatin, Nab-Paclitaxel, Durvalumab Before Surgery and Adjuvant Therapy in Head and Neck Squamous Cell Carcinoma

GastrointestinalHead & Neck

39 enrolled 8 charts

Squamous Cell Carcinoma of Head and Neck, Carcinoma, Squamous Cell, Esophageal Neoplasms, Laryngeal Neoplasms, Lip Neoplasms, Mouth Neoplasms, Oropharyngeal Neoplasms

NCT04713449 2026-02-23

Enhancing Self Care Among Oral Cancer Survivors: The Empowered Survival Trial

643 enrolled

Head and Neck Neoplasms, Mouth Neoplasms, Oropharyngeal Neoplasms

NCT07426874 2026-02-23

eHealth Support Tool to Improve Quality of Life in Head and Neck Cancer Survivors

Head and Neck Neoplasms

NCT03729518 2026-02-20

TORS De-Intensification Protocol Version 2.0: Dose and Volume Reduction in the Neck

150 enrolled

Carcinoma, Squamous Cell, Oropharyngeal Neoplasms

NCT04258813 2026-02-20

ONE TEAM

BreastGastrointestinalGenitourinaryGynecologicHead & NeckThoracic

313 enrolled

Breast Neoplasms, Carcinoma, Non-Small-Cell Lung, Carcinoma, Renal Cell, Cardiovascular Diseases, Colonic Neoplasms, Diabetes Mellitus, Esophageal Neoplasms, Head and Neck Neoplasms, Hypercholesterolemia, Hypertension, Liver Neoplasms, Neoplasms, Ovarian Neoplasms, Pancreatic Neoplasms, Prostatic Neoplasms, Endometrial Neoplasms

NCT04675710 2026-02-19

Pembrolizumab, Dabrafenib, and Trametinib Before Surgery for the Treatment of BRAF-Mutated Anaplastic Thyroid Cancer

Thyroid Carcinoma, Anaplastic

NCT04890834 2026-02-19

Dyadic Yoga Intervention for the Improvement of Healthcare Utilization and Quality of Life in Patients With Head and Neck Cancer Undergoing Chemoradiation and Their Caregivers

415 enrolled

Phase 3 Active not recruiting

Head and Neck Carcinoma

NCT04967391 2026-02-18

Tumescence in HNC Skin Graft Reconstruction

58 enrolled

Phase 1/2 Active not recruiting

Head and Neck Neoplasms

NCT06237881 2026-02-18

A Phase 1/2 Study of KSQ-001EX, Autologous Tumor Infiltrating Lymphocytes Engineered to Inactivate the SOCS1 Gene, in Patients With Select Advanced Solid Tumors

15 enrolled

DermatologicHead & NeckThoracic

Head and Neck Neoplasms, Lung Neoplasms, Melanoma

NCT07407205 2026-02-17

Tumor Mutational Burden, Liquid Biopsy, Angiogenic Factors and DCE-MRI Perfusion in HPV-Negative Oropharyngeal Cancer

Phase 1/2 Active not recruiting

Squamous Cell Carcinoma of Head and Neck, Oropharyngeal Neoplasms

NCT03085147 2026-02-12

A Dye for the Detection of Cancer of the Tongue and Mouth

23 enrolled

Squamous Cell Carcinoma of Head and Neck

NCT04151134 2026-02-12

MOSES

100 enrolled

Squamous Cell Carcinoma of Head and Neck

NCT04603248 2026-02-12

A Study for Identification of Immune Determinants for Response to Nivolumab in Recurrent and/or Metastatic Head and Neck Squamous Cell Carcinoma

50 enrolled

Squamous Cell Carcinoma of Head and Neck

NCT02143726 2026-02-11

Sorafenib Tosylate With or Without Everolimus in Treating Patients With Advanced, Radioactive Iodine Refractory Hurthle Cell Thyroid Cancer

35 enrolled 14 charts

Thyroid cancer, Hurthle cell

NCT02749903 2026-02-11

Enzalutamide for Patients With Androgen Receptor Positive Salivary Cancers

46 enrolled 11 charts

Salivary Cancer

NCT04862650 2026-02-10

Cemiplimab, Low-Dose Paclitaxel and Carboplatin for the Treatment of Recurrent/Metastatic Squamous Cell Carcinoma of the Head and Neck

46 enrolled

Squamous Cell Carcinoma of Head and Neck, Hypopharyngeal Neoplasms, Laryngeal Neoplasms, Mouth Neoplasms, Oropharyngeal Neoplasms

NCT05286060 2026-02-09

GENUINE

56 enrolled

Squamous Cell Carcinoma of Head and Neck

NCT03777384 2026-02-06

EValuating the Safety Of De-escaLated Head and Neck Irradiation in HPV positivE Oropharynx Cancer in Non-smokers/Minimal Smokers

75 enrolled

Head and Neck Neoplasms, Oropharyngeal Neoplasms

NCT05325970 2026-02-06

ORARAD II

350 enrolled

Head and Neck Neoplasms, Stomatognathic Diseases, Neoplasms, Osteoradionecrosis

NCT05980000 2026-02-06

Rambro2

37 enrolled

Squamous Cell Carcinoma of Head and Neck, Head and Neck Neoplasms

NCT07394842 2026-02-06

HN-ORAL-RT

100 enrolled